InventisBio Co., Limited (SHA:688382)

InventisBio Statistics

Total Valuation

InventisBio has a market cap or net worth of CNY 15.92 billion. The enterprise value is 14.41 billion.

Market Cap	15.92B
Enterprise Value	14.41B

Important Dates

The next estimated earnings date is Saturday, March 28, 2026.

Earnings Date	Mar 28, 2026
Ex-Dividend Date	n/a

Share Statistics

InventisBio has 578.35 million shares outstanding. The number of shares has increased by 1.23% in one year.

Current Share Class	578.35M
Shares Outstanding	578.35M
Shares Change (YoY)	+1.23%
Shares Change (QoQ)	+9.85%
Owned by Insiders (%)	12.27%
Owned by Institutions (%)	23.43%
Float	387.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	88.20
PB Ratio	9.56
P/TBV Ratio	9.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-123.91
EV / Sales	79.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-116.47

Financial Position

The company has a current ratio of 21.28, with a Debt / Equity ratio of 0.01.

Current Ratio	21.28
Quick Ratio	21.13
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.17
Interest Coverage	-253.72

Financial Efficiency

Return on equity (ROE) is -6.84% and return on invested capital (ROIC) is -6.12%.

Return on Equity (ROE)	-6.84%
Return on Assets (ROA)	-5.76%
Return on Invested Capital (ROIC)	-6.12%
Return on Capital Employed (ROCE)	-10.01%
Revenue Per Employee	975,825
Profits Per Employee	-628,554
Employee Count	185
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

In the past 12 months, InventisBio has paid 139,153 in taxes.

Income Tax	139,153
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +106.27% in the last 52 weeks. The beta is 0.26, so InventisBio's price volatility has been lower than the market average.

Beta (5Y)	0.26
52-Week Price Change	+106.27%
50-Day Moving Average	28.81
200-Day Moving Average	30.85
Relative Strength Index (RSI)	35.41
Average Volume (20 Days)	12,962,688

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, InventisBio had revenue of CNY 180.53 million and -116.28 million in losses. Loss per share was -0.20.

Revenue	180.53M
Gross Profit	179.56M
Operating Income	-168.61M
Pretax Income	-116.14M
Net Income	-116.28M
EBITDA	-163.05M
EBIT	-168.61M
Loss Per Share	-0.20

Balance Sheet

The company has 1.53 billion in cash and 21.39 million in debt, with a net cash position of 1.51 billion or 2.62 per share.

Cash & Cash Equivalents	1.53B
Total Debt	21.39M
Net Cash	1.51B
Net Cash Per Share	2.62
Equity (Book Value)	1.67B
Book Value Per Share	2.88
Working Capital	1.63B

Cash Flow

In the last 12 months, operating cash flow was -112.43 million and capital expenditures -11.28 million, giving a free cash flow of -123.71 million.

Operating Cash Flow	-112.43M
Capital Expenditures	-11.28M
Free Cash Flow	-123.71M
FCF Per Share	-0.21

Margins

Gross margin is 99.47%, with operating and profit margins of -93.40% and -64.41%.

Gross Margin	99.47%
Operating Margin	-93.40%
Pretax Margin	-64.34%
Profit Margin	-64.41%
EBITDA Margin	-90.32%
EBIT Margin	-93.40%
FCF Margin	n/a

Dividends & Yields

InventisBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.23%
Shareholder Yield	-1.23%
Earnings Yield	-0.73%
FCF Yield	-0.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

InventisBio has an Altman Z-Score of 79.42 and a Piotroski F-Score of 4.

Altman Z-Score	79.42
Piotroski F-Score	4